DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 180 filers reported holding DIPLOMAT PHARMACY INC in Q3 2018. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $154,000 | -53.6% | 38,503 | -43.1% | 0.00% | -50.0% |
Q3 2019 | $332,000 | -38.1% | 67,686 | -23.2% | 0.00% | -33.3% |
Q2 2019 | $536,000 | +5.7% | 88,082 | +0.9% | 0.01% | 0.0% |
Q1 2019 | $507,000 | -56.8% | 87,315 | +0.2% | 0.01% | -60.0% |
Q4 2018 | $1,173,000 | -26.3% | 87,165 | +6.3% | 0.02% | 0.0% |
Q3 2018 | $1,592,000 | -11.2% | 82,032 | +16.9% | 0.02% | -16.7% |
Q2 2018 | $1,793,000 | +17.2% | 70,161 | -7.6% | 0.02% | +20.0% |
Q1 2018 | $1,530,000 | -5.9% | 75,933 | -6.3% | 0.02% | -6.2% |
Q4 2017 | $1,626,000 | +216.3% | 81,033 | +226.7% | 0.02% | +166.7% |
Q3 2017 | $514,000 | +52.5% | 24,800 | +8.8% | 0.01% | +20.0% |
Q2 2017 | $337,000 | -6.4% | 22,800 | +0.9% | 0.01% | 0.0% |
Q1 2017 | $360,000 | +29.5% | 22,600 | +2.3% | 0.01% | +25.0% |
Q4 2016 | $278,000 | -55.5% | 22,100 | -0.9% | 0.00% | -55.6% |
Q3 2016 | $625,000 | -5.0% | 22,300 | +18.6% | 0.01% | 0.0% |
Q2 2016 | $658,000 | +29.8% | 18,800 | +1.6% | 0.01% | +28.6% |
Q1 2016 | $507,000 | – | 18,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |